Files

T

Fabio 5a13be122b Legislation: batch E — CA TN VA VT WA WI WV WY

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

2026-07-06 17:28:36 -04:00

4.8 KiB

Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type

title

description

jurisdiction

legislature

session

identifier

citation

classification

subjects

status

primary_sponsors

version_count

action_count

vote_count

first_action

last_action

source

source_identifier

source_url

source_hash

vintage

source_snapshot

retrieved_at

confidence

Virginia HB 2200 (2023) — Anti-cancer drugs; analyzing current reimbursement, etc., for medical practices that administer.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

CHAP0582 (committee substitute) — source
Committee substitute printed 23107067D-S1 (committee substitute) — source
HB2200ER (committee substitute) — source
Prefiled and ordered printed; offered 01/11/23 23103233D (committee substitute) — source

Votes

Reported from Finance and Appropriations with substitute (16-Y 0-N) — 0–0 (fail) · upper
VOTE: Passage (63-Y 35-N) — 0–0 (fail) · lower
Reported from Finance (14-Y 8-N) — 0–0 (fail) · lower
Subcommittee recommends reporting (6-Y 0-N) — 0–0 (fail) · lower
VOTE: Adoption (92-Y 0-N) — 0–0 (fail) · lower
Passed Senate with substitute (40-Y 0-N) — 0–0 (fail) · upper
Constitutional reading dispensed (40-Y 0-N) — 0–0 (fail) · upper

Timeline

The legislative action history — every referral, reading, and vote.

2023-01-11 Prefiled and ordered printed; offered 01/11/23 23103233D filing, introduction
2023-01-11 Referred to Committee on Finance referral-committee
2023-01-18 Impact statement from DHCD/CLG (HB2200)
2023-01-25 Impact statement from TAX (HB2200)
2023-01-26 Assigned Finance sub: Subcommittee #3 referral-committee
2023-01-30 Subcommittee recommends reporting (6-Y 0-N)
2023-02-01 Reported from Finance (14-Y 8-N) committee-passage
2023-02-03 Read first time reading-1
2023-02-06 Read second time and engrossed reading-2
2023-02-07 Read third time and passed House (63-Y 35-N) passage, reading-3
2023-02-07 VOTE: Passage (63-Y 35-N) passage
2023-02-08 Constitutional reading dispensed
2023-02-08 Referred to Committee on Finance and Appropriations referral-committee
2023-02-16 Reported from Finance and Appropriations with substitute (16-Y 0-N) committee-passage
2023-02-16 Senate committee, floor amendments and substitutes offered
2023-02-16 Committee substitute printed 23107067D-S1 substitution
2023-02-20 Constitutional reading dispensed (40-Y 0-N)
2023-02-21 Read third time reading-3
2023-02-21 Reading of substitute waived
2023-02-21 Committee substitute agreed to 23107067D-S1 substitution
2023-02-21 Engrossed by Senate - committee substitute HB2200S1 substitution
2023-02-21 Passed Senate with substitute (40-Y 0-N) passage
2023-02-22 Senate substitute agreed to by House 23107067D-S1 (92-Y 0-N) substitution
2023-02-22 VOTE: Adoption (92-Y 0-N)
2023-03-07 Enrolled enrolled
2023-03-07 Bill text as passed House and Senate (HB2200ER) passage
2023-03-08 Signed by Speaker passage
2023-03-08 Signed by President passage
2023-03-13 Enrolled Bill communicated to Governor on March 13, 2023 enrolled, executive-receipt
2023-03-13 Governor's Action Deadline 11:59 p.m., March 27, 2023 executive-receipt
2023-03-26 Approved by Governor-Chapter 582 (effective 7/1/23) executive-signature
2023-03-26 Acts of Assembly Chapter text (CHAP0582)

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/7686f958-b03c-408f-a3b7-0463cf240def. Confidence: reported (aggregated from official Virginia legislature records).

4.8 KiB Raw Permalink Blame History Unescape Escape